Ranbaxy and Merck & Co. Team Up To Develop Novel Anti-Infectives
By Helen Scrutton
PharmaDeals Review: Vol 2008 Issue 96 (Table of Contents)
Published: 12 May-2008
DOI: 10.3833/pdr.v2008i96.173 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Merck & Co entered into an agreement with Ranbaxy Laboratories to develop clinically validated anti-bacterial and anti-fungal drug candidates...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS